Clinical Trials on Bladder Cancer in United Kingdom
Total 24562 results
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
National Cancer Institute (NCI)RecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Renal Pelvis Cancer AJCC v8 | Stage IV Ureter Cancer... and other conditionsUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingBladder CancerUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); VA Long Beach Healthcare System; Nonagen Bioscience...Recruiting
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Locally Advanced Urothelial CarcinomaUnited States, Canada
-
University of Texas Southwestern Medical CenterRecruitingBladder Cancer | Radical CystectomyUnited States
-
National Cancer Institute (NCI)CompletedUrinary Bladder Neoplasms | Bladder Cancer | Urothelial CarcinomaUnited States
-
University of Colorado, DenverCompleted
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Memorial Sloan Kettering Cancer CenterBayerTerminatedBladder Cancer | URINARY BLADDERUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruiting
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingBladder CancerUnited States
-
PhotocureNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruiting
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Mundipharma Research LimitedTerminatedSevere Caner PainUnited Kingdom
-
University of Colorado, DenverAmerican Cancer Society, Inc.Recruiting
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
National Cancer Institute (NCI)CompletedUrinary Bladder NeoplasmsUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, San Francisco; Fred... and other collaboratorsActive, not recruitingBladder CancerUnited States, Japan
-
ADC Therapeutics S.A.TerminatedBreast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal CancerUnited States, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Avacta Life Sciences LtdRecruitingSoft Tissue Sarcoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Biliary Tract Cancer | Oesophageal Cancer | Cancer of Unknown Primary SiteUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Icahn School of Medicine at Mount SinaiPfizerRecruitingFocus Group | Screening ToolUnited States
-
Abramson Cancer Center at Penn MedicineCompletedBladder CancerUnited States
-
University of CincinnatiActive, not recruiting
-
Abramson Cancer Center at Penn MedicineAmerican Urological AssociationEnrolling by invitation
-
University of Texas Southwestern Medical CenterTerminatedBladder CancerUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
Power Life Sciences Inc.Not yet recruitingBladder CancerUnited States
-
Weill Medical College of Cornell UniversityEli Lilly and CompanyRecruitingBladder CancerUnited States
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
Matthew GalskyCelgeneTerminatedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Anthra PharmaceuticalsUnknownBladder CancerUnited States, Canada
-
Arquer Diagnostics LtdRecruiting
-
Medical Diagnostic Laboratories, LLCUnknownBladder Cancer | Hematuria | DysuriaUnited States
-
PhotocureCompletedBladder CancerUnited States, Canada, Austria, Germany, Netherlands